Thrombus

Rose P, O’Hare G. Multidisciplinary management of VTE. Thrombus, 2008; 12.4: 4–5.

Reference list

1. Douketis JD, Kearon C, Bates S et al. Risk of fatal pulmonary embolism in patients with treated venous thromboembolism. JAMA 1999; 299: 458–462.

2. Agnelli G, Prandoni P, Santamaria MG et al. Three months versus one year of oral anticoagulation therapy for idiopathic deep vein thrombosis. N Engl J Med 2001; 345:
165–169.

3. Kearon C, Gent M, Hirsh J et al. A comparison of three months of anticoagulation with extended anticoagulation for a first episode of idiopathic venous thromboembolism. N Engl J Med 1999; 340: 901–907.

4. Wells PS, Anderson DR, Bormanis J et al. Value of assessment of patient probability of deep vein thrombosis in clinical management. Lancet 1997; 350: 1795–1798.

5. Cope E, Rose PE. Management of deep vein thrombosis in the community. GP Update 2008; 1: 58–63.

6. Wells PS, Owen C, Doucette S, Ferusson D, Tan H. Does this patient have deep vein thrombosis? JAMA 2006; 295: 199–207.

7. Baglin TP, Keeling DM, Watson HG. Guidelines on oral anticoagulation (warfarin) third edition – 2005 update. Br J Haematol 2006; 132: 277–285.

8. Palareti G, Cosmi B, Legnani C et al. D-dimer testing to determine the duration of anticoagulation therapy. N Engl J Med 2006; 355: 1780–1789.

9. Nieto JA, Camara T, Gonalez-Higueras E et al. Clinical outcome of patients with major bleeding after venous thromboembolism – Findings from the RIETE Registry. Thromb Haemst 2008; 100: 789–796.

10. Kahn SR. The post thrombotic syndrome: progress and pitfalls. Br J Haematol 2006; 134: 357–365.

11. Prandoni P, Lensing AW, Cogo A et al. The long-term clinical course of acute deep vein thrombosis. Ann Inter Med 1996; 125: 1–7.

12. Rose P, Lester Z, Shankara P et al. Endocrine and CNS malignancies are strongly associated with symptomatic venous thromboembolism: findings from the VERITY registry. BJ Haematol 2007; 137 (Suppl 1): 164.

Published by Hayward Medical Communications

www.hayward.co.uk